Eponemycin and epoxomicin analogs and uses thereof
US7524883B2 · kind B2 · utility
0Cited by
2References
52Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 8, 2003 |
| Grant date | Apr 28, 2009 |
| Priority date | — |
| Expiry date | Apr 20, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds having formula (1): wherein R1-R6, A, J, D, E, G, Q, w, x, y, and z are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof in the treatment of cancer and/or inflammatory disorders, and more generally as proteasome inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.